PIGNOCHINO, Ymera
 Distribuzione geografica
Continente #
NA - Nord America 2.618
EU - Europa 1.553
AS - Asia 905
SA - Sud America 49
OC - Oceania 11
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.146
Nazione #
US - Stati Uniti d'America 2.517
CN - Cina 573
IT - Italia 524
DE - Germania 219
IE - Irlanda 142
GB - Regno Unito 138
SE - Svezia 95
FR - Francia 92
CA - Canada 86
JP - Giappone 86
FI - Finlandia 51
KR - Corea 50
UA - Ucraina 49
VN - Vietnam 48
ES - Italia 43
PL - Polonia 38
BR - Brasile 29
TR - Turchia 27
IN - India 26
NL - Olanda 24
TW - Taiwan 24
AT - Austria 23
BE - Belgio 19
SG - Singapore 18
NO - Norvegia 17
RU - Federazione Russa 16
HK - Hong Kong 14
CH - Svizzera 13
TH - Thailandia 12
AU - Australia 11
MX - Messico 11
PT - Portogallo 9
HR - Croazia 8
AR - Argentina 7
CO - Colombia 6
SA - Arabia Saudita 6
IL - Israele 5
RO - Romania 5
HU - Ungheria 4
LT - Lituania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DK - Danimarca 3
GR - Grecia 3
IR - Iran 3
MK - Macedonia 3
PA - Panama 3
ZA - Sudafrica 3
AM - Armenia 2
EU - Europa 2
JO - Giordania 2
MA - Marocco 2
RS - Serbia 2
SN - Senegal 2
BT - Bhutan 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
ID - Indonesia 1
LU - Lussemburgo 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.146
Città #
Chandler 316
Beijing 194
Fairfield 194
Dublin 141
Woodbridge 128
Ann Arbor 125
Houston 116
Torino 115
Ashburn 111
Seattle 94
Wilmington 79
Mcallen 75
Cambridge 71
Shanghai 67
Munich 66
Nyköping 59
Montréal 58
Jacksonville 56
Redwood City 52
Medford 50
Dearborn 49
Turin 44
Pisa 42
Villeurbanne 42
Princeton 41
Milan 39
Guangzhou 36
Warsaw 32
Hangzhou 29
Dong Ket 28
Nanjing 24
Fremont 20
Cuneo 19
New York 18
Tokyo 17
Boston 16
Madrid 15
San Diego 15
Vienna 14
Taipei 13
Wuhan 13
Hebei 12
Xian 12
Brussels 11
Changsha 11
Dresden 11
Stavanger 11
Zhengzhou 11
Rome 10
Seoul 10
Bari 9
Chengdu 9
Kunming 9
Berlin 8
Carrara 8
Hefei 8
Heidelberg 8
Tianjin 8
Upper Marlboro 8
Buenos Aires 7
Istanbul 7
Los Angeles 7
Ottawa 7
Singapore 7
Washington 7
Amsterdam 6
Brescia 6
Falls Church 6
Mountain View 6
New Haven 6
Norwalk 6
Padova 6
Paris 6
Phoenix 6
Silver Spring 6
St Petersburg 6
Toronto 6
Tübingen 6
A Coruña 5
Birmingham 5
Cagliari 5
Chicago 5
Columbus 5
Esslingen 5
Fuzhou 5
Genoa 5
Graz 5
Helsinki 5
Jinan 5
Mumbai 5
Paredes 5
Rochester 5
Settimo Torinese 5
Stuttgart 5
Verona 5
Boardman 4
Bologna 4
Brookline 4
Buffalo 4
Bydgoszcz 4
Totale 3.132
Nome #
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial 1.041
Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature. 310
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells 303
Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy 296
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group 267
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models 192
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. 169
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 146
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 142
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 133
Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights 131
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways 118
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma 113
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas 101
ZnO nanocrystals shuttled by extracellular vesicles as effective Trojan nano-horses against cancer cells 99
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 94
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. 93
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab 92
Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice 90
Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions 81
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 78
Adoptive immunotherapy against sarcomas. 78
Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study 76
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. 75
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. 68
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. 62
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group 62
Sustained Long Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors 62
Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors 60
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour 60
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 58
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 58
Crosstalk between macrophages and myxoid liposarcoma cells increases spreading and invasiveness of tumor cells 54
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 49
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways 48
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 48
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 48
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma. 44
Delving into PARP inhibition from bench to bedside and back 42
Enhancing proteotoxic stress in leiomyosarcoma cells triggers mitochondrial dysfunctions, cell death, and antitumor activity in vivo 42
Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma 33
Targeting of epidermal growth factor receptor in patients affected by biliary tract carcinoma 32
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST 28
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma 10
Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients 8
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application 3
Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach 2
CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles 1
Totale 5.300
Categoria #
all - tutte 12.902
article - articoli 0
book - libri 0
conference - conferenze 478
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019155 0 0 0 0 0 0 0 0 0 0 102 53
2019/2020874 55 57 38 78 46 103 83 71 95 94 84 70
2020/2021805 76 102 82 70 59 72 38 54 55 80 31 86
2021/2022826 119 48 38 53 34 40 44 46 29 72 173 130
2022/2023962 79 89 31 105 65 205 76 56 108 34 74 40
2023/2024466 62 95 31 50 47 67 23 40 12 36 3 0
Totale 5.300